Ohr Pharmaceutical Inc (OHRP):企業の財務・戦略的SWOT分析

◆英語タイトル:Ohr Pharmaceutical Inc (OHRP) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14841
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ohr Pharmaceutical Inc (Ohr), formerly BBM Holdings Inc, is a pharmaceutical company that develops novel therapies for ophthalmic diseases. The company offers products such as squalamine lactate ophthalmic solution and SKS sustained release technology products. Its squalamine lactate ophthalmic solution is used in wet age-related macular degeneration, retinal vein occlusion, proliferative diabetic retinopathy and diabetic macular edema indications. Ohr has a sustained-release micro-fabricated micro-particle ocular drug delivery platform technology that utilizes hydrogel template approach to prepare microparticles or other configurations. The company also conducts programs for the treatment of ocular conditions including primary open angle glaucoma, steroid-induced glaucoma, ocular allergy, and retinal diseases. It operates through its research facilities in San Diego, the US. Ohr is headquartered in New York, the US.

Ohr Pharmaceutical Inc Key Recent Developments

Feb 14,2019: Ohr Pharmaceutical reports financial results for the fiscal first quarter of 2019
Aug 14,2018: Ohr Pharmaceutical reports fiscal third quarter 2018 financial results
May 15,2018: Ohr Pharmaceutical Announces Fiscal Second Quarter 2018 Financial Results
Feb 14,2018: Ohr Pharmaceutical Reports Q1 Fiscal 2018 Financial Results

This comprehensive SWOT profile of Ohr Pharmaceutical Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Ohr Pharmaceutical Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Ohr Pharmaceutical Inc – Key Information
Ohr Pharmaceutical Inc – Overview
Ohr Pharmaceutical Inc – Key Employees
Ohr Pharmaceutical Inc – Key Employee Biographies
Ohr Pharmaceutical Inc – Key Operational Heads
Ohr Pharmaceutical Inc – Major Products and Services
Ohr Pharmaceutical Inc – History
Ohr Pharmaceutical Inc – Company Statement
Ohr Pharmaceutical Inc – Locations And Subsidiaries
Ohr Pharmaceutical Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Ohr Pharmaceutical Inc – Business Description
Ohr Pharmaceutical Inc – Corporate Strategy
Ohr Pharmaceutical Inc – SWOT Analysis
SWOT Analysis – Overview
Ohr Pharmaceutical Inc – Strengths
Ohr Pharmaceutical Inc – Weaknesses
Ohr Pharmaceutical Inc – Opportunities
Ohr Pharmaceutical Inc – Threats
Ohr Pharmaceutical Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Ohr Pharmaceutical Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Ohr Pharmaceutical Inc, Key Information
Ohr Pharmaceutical Inc, Key Ratios
Ohr Pharmaceutical Inc, Share Data
Ohr Pharmaceutical Inc, Major Products and Services
Ohr Pharmaceutical Inc, History
Ohr Pharmaceutical Inc, Key Employees
Ohr Pharmaceutical Inc, Key Employee Biographies
Ohr Pharmaceutical Inc, Key Operational Heads
Ohr Pharmaceutical Inc, Other Locations
Ohr Pharmaceutical Inc, Subsidiaries
Ohr Pharmaceutical Inc, Key Manufacturing facilities
Ohr Pharmaceutical Inc, Key Competitors
Ohr Pharmaceutical Inc, SWOT Analysis
Ohr Pharmaceutical Inc, Ratios based on current share price
Ohr Pharmaceutical Inc, Annual Ratios
Ohr Pharmaceutical Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Ohr Pharmaceutical Inc, Performance Chart
Ohr Pharmaceutical Inc, Ratio Charts

★海外企業調査レポート[Ohr Pharmaceutical Inc (OHRP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AGA Rangemaster Group Ltd:企業の戦略的SWOT分析
    AGA Rangemaster Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Terrain Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Terrain Energy Ltd (Terrain Energy) is an oil and gas company that offers oil and gas exploration and production services. The company’s services include acquiring, operations, production, management and development of oil and gas producing basins in the onshore UK. It owns and operates onsh …
  • Famous Dave’s of America, Inc.:企業の戦略・SWOT・財務情報
    Famous Dave's of America, Inc. - Strategy, SWOT and Corporate Finance Report Summary Famous Dave's of America, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Hindustan Construction Co Ltd (HCC):企業の財務・戦略的SWOT分析
    Hindustan Construction Co Ltd (HCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Focus Media Holding Ltd:企業のM&A・事業提携・投資動向
    Focus Media Holding Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Focus Media Holding Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Assima PLC (ALSIM):企業の財務・戦略的SWOT分析
    Summary Assima PLC (Assima), formerly Assima Ltd, is a technology company that develops and distributes cloning solutions. The company provides products such as assima training suite, assima multilingual suite, vimago, vimago train, vimago assist, vimago analyze, vimago collaborate, assima software …
  • Sinopec Shanghai Petrochemical Company Limited:戦略・SWOT・企業財務分析
    Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Venus Remedies Ltd (VENUSREM)-製薬・医療分野:企業M&A・提携分析
    Summary Venus Remedies Ltd (Venus) is a pharmaceutical company that develops, manufactures and commercializes research, herbal and generic products. The company manufactures complex formulations for oncology injections, neurology, antiseptic, pain management, anti infectives, oncology lyophilized, l …
  • Sunrise Medical (US) LLC:企業の戦略的SWOT分析
    Sunrise Medical (US) LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Logicbio Therapeutics Inc (LOGC):製薬・医療:M&Aディール及び事業提携情報
    Summary Logicbio Therapeutics Inc (Logicbio) is a genome-editing company with focus on the development of transformative medicines for the treatment of hematological and genetic disorders. Its pipeline product candidates include LB-101 for treating Hemophilia B; LB-201 against inborn error of metabo …
  • Oneida Ltd.:企業の戦略的SWOT分析
    Oneida Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Catalyst Pharmaceuticals Inc (CPRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Catalyst Pharmaceuticals Inc (Catalyst) is a biopharmaceutical company that develops prescription drugs targeting rare neurological and neuromuscular diseases. The company focuses on specific conditions such as infantile spasms, complex partial seizures, Lambert-Eaton myasthenic syndrome (LE …
  • Shenzhen Kaifa Technology Co Ltd (000021):企業の財務・戦略的SWOT分析
    Shenzhen Kaifa Technology Co Ltd (000021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Sri Lanka Telecom PLC (SLTL.N0000):企業の財務・戦略的SWOT分析
    Sri Lanka Telecom PLC (SLTL.N0000) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • MicroStrategy Inc (MSTR):企業の財務・戦略的SWOT分析
    MicroStrategy Inc (MSTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • VTB Bank:企業のM&A・事業提携・投資動向
    VTB Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's VTB Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Limacorporate SpA-医療機器分野:企業M&A・提携分析
    Summary Limacorporate SpA (Lima) is a medical device company that offers reconstructive and fixation orthopaedic solutions. The company offers large joint primary, large joint revision, extremities and fixation and promade products. It offers medical products for knee, hip, shoulder, cups, small joi …
  • Neuway Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Neuway Pharma GmbH (Neuway) is a provider of preclinical and clinical development for the treatment of central nervous system diseases. The company provides proprietary CNS drug delivery platform facilitates the transport of active drug substances through the blood-brain barrier. Its technol …
  • Grupa Azoty Zaklady Chemiczne Police SA (PCE):企業の財務・戦略的SWOT分析
    Grupa Azoty Zaklady Chemiczne Police SA (PCE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Novant Health Inc:企業の戦略的SWOT分析
    Novant Health Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆